Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

SPRY

ARS Pharmaceuticals Inc

May 29 • 04:00PM ET

9.07

-0.33 -3.51 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: HRMY SUPN ALKS PRGO BHC AMRX INDV LNTH TEVA VTRS

| Held by: XBI VTI IWM VXF IWO IBB SCHA VTWO SMLF VHT

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-2.00	Insider Own	36.89%	Shs Outstand	99.30M	Perf Week	10.21%
Market Cap	900.68M	Forward P/E	-	EPS next Y	-0.96	Insider Trans	0.00%	Shs Float	62.67M	Perf Month	15.69%
Enterprise Value	796.82M	PEG	-	EPS next Q	-0.48	Inst Own	74.30%	Short Float	41.35%	Perf Quarter	-2.26%
Income	-197.98M	P/S	9.10	EPS this Y	-0.57%	Inst Trans	-1.00%	Short Ratio	15.45	Perf Half Y	-2.26%
Sales	98.99M	P/B	14.69	EPS next Y	45.37%	ROA	-64.39%	Short Interest	25.91M	Perf YTD	-22.15%
Book/sh	0.62	P/C	4.48	EPS next 5Y	-	ROE	-136.40%	52W High	18.90 -52.01%	Perf Year	-41.45%
Cash/sh	2.02	P/FCF	-	EPS past 3/5Y	-26.04% -12.85%	ROIC	-125.44%	52W Low	6.66 36.19%	Perf 3Y	23.07%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	300.09% -	Gross Margin	74.12%	Volatility	7.21% 7.12%	Perf 5Y	-67.05%
Dividend TTM	-	EV/Sales	8.05	EPS Y/Y TTM	-1130.30%	Oper. Margin	-204.49%	ATR (14)	0.59	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	4.77	Sales Y/Y TTM	1.92%	Profit Margin	-200.00%	RSI (14)	59.10	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	4.94	EPS Q/Q	-76.39%	SMA20	8.22%	Beta	0.95	Target Price	29.20
Payout	-	Debt/Eq	1.58	Sales Q/Q	184.47%	SMA50	10.45%	Rel Volume	1.28	Prev Close	9.40
Employees	163	LT Debt/Eq	1.57	Earnings	May 15 BMO	SMA200	-6.40%	Avg Volume	1.68M	Price	9.07
IPO	Dec 04, 2020	Option/Short	Yes / Yes	EPS/Sales Surpr.	-18.22% 2.17%	Trades		Volume	2,146,307	Change	-3.51%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)